Ameriprise’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-67,607
| Closed | -$478K | – | 4040 |
|
2024
Q4 | $478K | Sell |
67,607
-76,531
| -53% | -$541K | ﹤0.01% | 3513 |
|
2024
Q3 | $1.17M | Sell |
144,138
-167,522
| -54% | -$1.36M | ﹤0.01% | 3144 |
|
2024
Q2 | $1.99M | Sell |
311,660
-113,495
| -27% | -$725K | ﹤0.01% | 2867 |
|
2024
Q1 | $3.2M | Sell |
425,155
-19,574
| -4% | -$147K | ﹤0.01% | 2633 |
|
2023
Q4 | $4.12M | Sell |
444,729
-49,111
| -10% | -$455K | ﹤0.01% | 2492 |
|
2023
Q3 | $5M | Buy |
493,840
+144,938
| +42% | +$1.47M | ﹤0.01% | 2297 |
|
2023
Q2 | $4.36M | Sell |
348,902
-7,510
| -2% | -$93.9K | ﹤0.01% | 2447 |
|
2023
Q1 | $4.16M | Buy |
356,412
+80,173
| +29% | +$936K | ﹤0.01% | 2440 |
|
2022
Q4 | $2.94M | Sell |
276,239
-25,081
| -8% | -$267K | ﹤0.01% | 2620 |
|
2022
Q3 | $2.92M | Buy |
301,320
+195,066
| +184% | +$1.89M | ﹤0.01% | 2583 |
|
2022
Q2 | $1.54M | Buy |
+106,254
| New | +$1.54M | ﹤0.01% | 2921 |
|
2020
Q3 | – | Sell |
-70,314
| Closed | -$2.05M | – | 3749 |
|
2020
Q2 | $2.05M | Buy |
70,314
+38,285
| +120% | +$1.12M | ﹤0.01% | 2591 |
|
2020
Q1 | $837K | Buy |
32,029
+8,915
| +39% | +$233K | ﹤0.01% | 2900 |
|
2019
Q4 | $802K | Buy |
23,114
+1,505
| +7% | +$52.2K | ﹤0.01% | 3153 |
|
2019
Q3 | $684K | Buy |
+21,609
| New | +$684K | ﹤0.01% | 3174 |
|